Judge Raps Cipla For 'Extreme' Suppression Step In Drug Suit
By Daniel Wilson · October 28, 2026, 3:23 PM AEST
A Federal Court judge has awarded costs against drugmaker Cipla after it tried to suppress information related to its planned generic drug during patent infringement lawsuits brought by U.S. pharmaceutical giant...
To view the full article, register now.
Try Law360 Australia FREE for fourteen days
Already a subscriber? Click here to login